
Mydekla 60mg Tablet
Salt Composition: daclatasvir dihydrochloride(60)
Expiry Date: 01/2028
Inclusive of all taxes
28 Tablet in Bottle
About The Product
Hepatitis C
Mydekla 60mg tablet is a prescription-based antiviral medicine. This tablet is used with other medications in the treatment of chronic (long-lasting) Hepatitis C Virus infection in adults. The active ingredient of the Mydekla tablet is Daclatasvir. Daclatasvir is a direct-acting antiviral (DAA) agent that works against Hepatitis C Virus(HCV) and is used for the treatment of chronic HCV genotype 1 and 3 infections.
Side Effects
- Mydekla 60mg tablet may cause some side effects that vary from one patient to another.
- Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
- Common side effects include: Fatigue Headache Nausea Insomnia (difficulty in sleeping)
- Anemia Diarrhea Skin rash Dizziness Drowsiness Unusual tiredness Vomiting Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
- The doctor determines the dosage of Mydekla 60mg tablet as per the patient's health and other medical conditions.
- Take this medicine at the same time every day as prescribed by your doctor for effective results.
- It can be taken orally, with or without food.
- In case of an overdose, contact your doctor immediately.
Safety Advice
It is advisable not to consume alcohol while taking this medicine.
Do not take Mydekla 60mg tablets without consulting your doctor if you are pregnant.
Do not take this medicine while breastfeeding without consulting a doctor.
It is recommended not to drive or operate heavy machinery, as this medicine may cause side effects that impair your ability to do so.
Consult your doctor before taking Mydekla 60mg tablets if you have any kidney problems.
Inform your doctor about your medical history regarding liver disease before starting treatment with Mydekla 60mg
Missed Doses
- If you miss a dose, make sure to take it as soon as you remember.
- Skip the missed dose in case it is already the time for your next scheduled dose.
- Do not double the dose to catch up.
FAQs
Mydekla 60mg tablet is an antiviral medicine.
This tablet is used with other medications to treat chronic Hepatitis C virus infection in adults.
Reference
1. Bunchorntavakul, C., & Reddy, K.
R. (2015).
The efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection. Alimentary pharmacology & therapeutics, 42(3), 258-272.
2. Montgomery, M., Ho, N., Chung, E., & Marzella, N.
(2016). Daclatasvir (Daklinza): a treatment option for chronic hepatitis C infection.
Pharmacy and Therapeutics, 41(12), 751. 3.
Gandhi, Y., Eley, T., Fura, A., Li, W., Bertz, R. J., & Garimella, T.
(2018). Daclatasvir: a review of preclinical and clinical pharmacokinetics.
Clinical pharmacokinetics, 57(8), 911-928. 4.
Yang, S. S., & Kao, J.
H. (2016).
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection. Hepatology international, 10(2), 258-266.
5. Keating, G.
M. (2016).
Daclatasvir: a review in chronic hepatitis C. Drugs, 76(14), 1381-1391.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.